286 related articles for article (PubMed ID: 6310445)
1. Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
Wobbes T; Schraffordt Koops H; Oldhoff J; Sleijfer DT; Oosterhuis JW
Neth J Surg; 1983 Jul; 35(3):89-93. PubMed ID: 6310445
[No Abstract] [Full Text] [Related]
2. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
3. Optimal management of retroperitoneal metastatic nonseminomatous testicular cancer: toward a better selection between scalpel and needle.
de Wit R
J Clin Oncol; 2007 Dec; 25(35):5550-2. PubMed ID: 18065727
[No Abstract] [Full Text] [Related]
4. Management of patients with non-seminomatous germ cell tumours stage I.
Rørth M; Cullen MH; Horwich A; Roth BJ
Prog Clin Biol Res; 1990; 357():295-303. PubMed ID: 2170995
[No Abstract] [Full Text] [Related]
5. [Relapses of malignant nonseminomatous germinal testicular tumors].
Piot G; Droz JP; Caillaud JM; Bellet D; Wibault P; Brulé G; Amiel JL
J Urol (Paris); 1983; 89(1):49-51. PubMed ID: 6302168
[TBL] [Abstract][Full Text] [Related]
6. Non-seminomatous germ cell testis tumors--how do you manage clinical state IIA?
Whitmore WF
Prog Clin Biol Res; 1985; 203():571-4. PubMed ID: 3008185
[No Abstract] [Full Text] [Related]
7. The management of non-seminomatous germ-cell tumours patients with viable malignancy at the time of RPLND.
Huddart RA
Ann Oncol; 2008 Feb; 19(2):203-4. PubMed ID: 18245130
[No Abstract] [Full Text] [Related]
8. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of clinical staging and efficacy of treatment in non-seminomatous germ-cell tumours of the testis.
de Kock ML; Allen FJ; Breytenbach IH; van der Merwe AM
S Afr J Surg; 1987 Sep; 25(3):87-9. PubMed ID: 2825363
[No Abstract] [Full Text] [Related]
10. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
[TBL] [Abstract][Full Text] [Related]
11. Is there still a place for lymphadenectomy in clinical stage I non-seminoma?
Weissbach L; Boedefeld EA; Bussar-Maatz R; Kleinschmidt K
Prog Clin Biol Res; 1988; 269():407-17. PubMed ID: 2839848
[No Abstract] [Full Text] [Related]
12. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
13. [Management of localized germ-cell tumours of the testis].
Loriot Y; Fizazi K
Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
[TBL] [Abstract][Full Text] [Related]
14. Wait-and-see policy in clinical stage I non-seminomatous germ cell tumors of the testis.
Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Marrink J; de Bruijn HW; Oldhoff J
Eur J Surg Oncol; 1986 Sep; 12(3):283-7. PubMed ID: 3019779
[TBL] [Abstract][Full Text] [Related]
15. [The results of combined treatment for testicular tumours. Report of 12 cases (author's transl)].
Osterhage HR; Jellinghaus W; Reichert HE
J Urol (Paris); 1982; 88(2):97-9. PubMed ID: 6284839
[TBL] [Abstract][Full Text] [Related]
16. Surveillance in stage I nonseminomatous germ cell tumours of the testis.
Zuniga A; Kakiashvili D; Jewett MA
BJU Int; 2009 Nov; 104(9 Pt B):1351-6. PubMed ID: 19840012
[No Abstract] [Full Text] [Related]
17. Management of stages I and II nonseminomatous germ cell tumors of the testis.
Babaian RJ; Johnson DE
Cancer; 1980 Apr; 45(7 Suppl):1775-81. PubMed ID: 7189442
[No Abstract] [Full Text] [Related]
18. Redefining the refined retroperitoneal lymph node dissection in testis cancer: a SWOT analysis of nonrandomized data.
Garnick MB
J Clin Oncol; 2007 Oct; 25(28):4337-8. PubMed ID: 17906195
[No Abstract] [Full Text] [Related]
19. Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I.
Fosså SD; Ous S; Stenwig AE; Lien HH; Aass N; Kaalhus O
Eur Urol; 1990; 17(2):107-12. PubMed ID: 2155789
[TBL] [Abstract][Full Text] [Related]
20. Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A review.
Droz JP; van Oosterom AT
Eur J Cancer; 1993; 29A(7):1038-44. PubMed ID: 8388697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
